In breast cancer cells (MCF-7 and MDA-MB-468), during nutrient deprivation or treatment with inhibitors of growth factor receptors, eEF2K is activated due to inhibition of the mTORC1/S6 kinase pathway. This evidence concerns the gene EEF2K and breast carcinoma.